Zobrazeno 1 - 10
of 103
pro vyhledávání: '"Roy, F."'
Autor:
Yong MK; Department of Infectious Diseases, Peter MacCallum Cancer Centre, Melbourne, Victoria, 3000, Australia; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Victoria, 3000, Australia; Department of Infectious Diseases, Royal Melbourne Hospital, Melbourne Victoria, 3050, Australia. Electronic address: Michelle.Yong@petermac.org., Shigle TL; Division of Pharmacy, The University of Texas MD Anderson Cancer Centre, Houston, TX, USA., Kim YJ; Department of Pediatrics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea., Carpenter PA; Clinical Research Division, Fred Hutchinson Cancer Research Centre, Seattle, WA, USA., Chemaly RF; Department of Infectious Diseases, Infection Control, & Employee Health, The University of Texas MD Anderson Cancer Centre, Houston, TX, USA., Papanicolaou GA; Infectious Diseases Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Publikováno v:
Transplantation and cellular therapy [Transplant Cell Ther] 2021 Dec; Vol. 27 (12), pp. 957-967. Date of Electronic Publication: 2021 Sep 21.
Autor:
Sassine J; Department of Infectious Diseases, Infection Control, and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Division of Infectious Diseases, Department of Medicine, The University of Texas Health Science Center at Houston, Houston, Texas, USA., Khawaja F; Department of Infectious Diseases, Infection Control, and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Shigle TL; Division of Pharmacy, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Handy V; Division of Pharmacy, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Foolad F; Department of Infectious Diseases, Infection Control, and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Aitken SL; Division of Pharmacy, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Jiang Y; Department of Infectious Diseases, Infection Control, and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Champlin R; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Shpall E; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Rezvani K; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Ariza-Heredia EJ; Department of Infectious Diseases, Infection Control, and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Chemaly RF; Department of Infectious Diseases, Infection Control, and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Publikováno v:
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2021 Oct 20; Vol. 73 (8), pp. 1346-1354.
Autor:
Goldsmith SR; Division of Oncology, Department of Medicine, Washington University School of Medicine, St Louis MO., Abid MB; Division of Hematology/Oncology and.; Division of Infectious Diseases, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI., Auletta JJ; Blood and Marrow Transplant Program and.; Host Defence Program, Division of Hematology/Oncology/Bone Marrow Transplant-Infectious Diseases, Nationwide Children's Hospital, Columbus, OH., Bashey A; Blood and Marrow Transplant Program, Northside Hospital, Atlanta, GA., Beitinjaneh A; Division of Transplantation and Cellular Therapy, University of Miami, Miami, FL., Castillo P; UF Health Shands Children's Hospital, Gainesville, FL., Chemaly RF; MD Anderson Cancer Center, Houston, TX., Chen M; Center for International Blood and Marrow Transplantation Research (CIBMTR), Department of Medicine, Medical College of Wisconsin, Milwaukee, WI., Ciurea S; Stem Cell Transplant and Cellular Therapies Service, University of California, Irvine, Orange, CA., Dandoy CE; Cincinnati Children's Hospital Medical Center, University of Cincinnati School of Medicine, Cincinnati, OH., Díaz MÁ; Department of Hematology/Oncology, Hospital Infantil Universitario Niño Jesus, Madrid, Spain., Fuchs E; The Sidney Kimmel Comprehensive Cancer Center, John Hopkins, Baltimore, MD., Ganguly S; Division of Hematological Malignancy and Cellular Therapeutics, University of Kansas Health System, Kansas City, KS., Kanakry CG; Experimental Transplantation and Immunotherapy Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD., Kanakry JA; Experimental Transplantation and Immunotherapy Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD., Kim S; Center for International Blood and Marrow Transplantation Research (CIBMTR), Department of Medicine, Medical College of Wisconsin, Milwaukee, WI.; Division of Biostatistics, Institute of Health and Equity, Medical College of Wisconsin, Milwaukee, WI., Komanduri KV; Hematology, Oncology, University of Miami, Miami, FL., Krem MM; Markey Cancer Center, University of Kentucky College of Medicine, Lexington, KY., Lazarus HM; University Hospitals Cleveland Medical Center, Case Western Reserve University, Cleveland, OH., Liu H; University of Chicago Medicine, Chicago, IL., Ljungman P; Department of Cellular Therapy and Allogeneic Stem Cell Transplantation, Karolinska University Hospital Huddinge, and.; Department of Medicine Huddinge, Karolinska Institutet, Stockholm, Sweden., Masiarz R; Adult Blood and Marrow Stem Cell Transplant Program, Knight Cancer Institute, Oregon Health and Science University, Portland, OR., Mulroney C; University of California, San Diego Medical Center, La Jolla, CA., Nathan S; Section of Bone Marrow Transplant and Cell Therapy, Rush University Medical Center, Chicago, IL., Nishihori T; Department of Blood & Marrow Transplant and Cellular Immunotherapy (BMT CI), Moffitt Cancer Center, Tampa, FL., Page KM; Division of Pediatric Blood and Marrow Transplantation, Duke University Medical Center, Durham, NC., Perales MA; Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY., Taplitz R; Division of Infectious Diseases, City of Hope National Medical Center, Duarte, CA., Romee R; Stem Cell Transplantation Program, Dana Farber Cancer Institute, Boston, MA; and., Riches M; Center for International Blood and Marrow Transplantation Research (CIBMTR), Department of Medicine, Medical College of Wisconsin, Milwaukee, WI.; Division of Hematology/Oncology, The University of North Carolina at Chapel Hill, Chapel Hill, NC.
Publikováno v:
Blood [Blood] 2021 Jun 10; Vol. 137 (23), pp. 3291-3305.
Autor:
Alsumali A; Center for Observational and Real-world Evidence, Merck & Co, Inc, Kenilworth, New Jersey., Chemaly RF; Department of Infectious Diseases, Infection Control, and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, Texas., Graham J; Health Economics, RTI Health Solutions, Research Triangle Park, North Carolina., Jiang Y; Center for Observational and Real-world Evidence, MSD Ltd, Hoddesdon, Hertfordshire, UK., Merchant S; Center for Observational and Real-world Evidence, Merck & Co, Inc, Kenilworth, New Jersey., Miles L; Health Economics, RTI Health Solutions, Research Triangle Park, North Carolina., Schelfhout J; Center for Observational and Real-world Evidence, Merck & Co, Inc, Kenilworth, New Jersey., Yang J; Center for Observational and Real-world Evidence, Merck & Co, Inc, Kenilworth, New Jersey., Tang Y; Center for Observational and Real-world Evidence, Merck & Co, Inc, Kenilworth, New Jersey.
Publikováno v:
Journal of medical virology [J Med Virol] 2021 Jun; Vol. 93 (6), pp. 3786-3794. Date of Electronic Publication: 2020 Oct 05.
Autor:
Khawaja F; Department of Infectious Diseases, Infection Control, and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Batista MV, El Haddad L, Chemaly RF
Publikováno v:
Current opinion in infectious diseases [Curr Opin Infect Dis] 2019 Dec; Vol. 32 (6), pp. 565-574.
Autor:
Ghobadi A; Department of Medicine, Washington University School of Medicine, St Louis, MO 63110, USA. Electronic address: arminghobadi@wustl.edu., Milton DR; The University of Texas MD Anderson Cancer Center, Department of Biostatistics, Houston, TX, USA., Gowda L; The University of Texas MD Anderson Cancer Center, Department of Stem Cell Transplantation and Cellular Therapy, Houston, TX, USA., Rondon G; The University of Texas MD Anderson Cancer Center, Department of Stem Cell Transplantation and Cellular Therapy, Houston, TX, USA., Chemaly RF; The University of Texas MD Anderson Cancer Center, Department of Infectious Diseases, Houston, TX, USA., Hamdi A; The University of Texas MD Anderson Cancer Center, Department of Stem Cell Transplantation and Cellular Therapy, Houston, TX, USA., Alousi A; The University of Texas MD Anderson Cancer Center, Department of Stem Cell Transplantation and Cellular Therapy, Houston, TX, USA., Afrough A; The University of Texas MD Anderson Cancer Center, Department of Stem Cell Transplantation and Cellular Therapy, Houston, TX, USA., Oran B; The University of Texas MD Anderson Cancer Center, Department of Stem Cell Transplantation and Cellular Therapy, Houston, TX, USA., Ciurea S; The University of Texas MD Anderson Cancer Center, Department of Stem Cell Transplantation and Cellular Therapy, Houston, TX, USA., Kebriaei P; The University of Texas MD Anderson Cancer Center, Department of Stem Cell Transplantation and Cellular Therapy, Houston, TX, USA., Popat UR; The University of Texas MD Anderson Cancer Center, Department of Stem Cell Transplantation and Cellular Therapy, Houston, TX, USA., Qazilbash MH; The University of Texas MD Anderson Cancer Center, Department of Stem Cell Transplantation and Cellular Therapy, Houston, TX, USA., Shpall EJ; The University of Texas MD Anderson Cancer Center, Department of Stem Cell Transplantation and Cellular Therapy, Houston, TX, USA., Champlin RE; The University of Texas MD Anderson Cancer Center, Department of Stem Cell Transplantation and Cellular Therapy, Houston, TX, USA., Bashir Q; The University of Texas MD Anderson Cancer Center, Department of Stem Cell Transplantation and Cellular Therapy, Houston, TX, USA.
Publikováno v:
Current research in translational medicine [Curr Res Transl Med] 2019 May; Vol. 67 (2), pp. 51-55. Date of Electronic Publication: 2019 Jan 23.
Autor:
El Haddad L; Department of Infectious Diseases, Infection Control, and Employee Health, The University of Texas MD Anderson Cancer Center, Houston., Ariza-Heredia E; Department of Infectious Diseases, Infection Control, and Employee Health, The University of Texas MD Anderson Cancer Center, Houston., Shah DP; Department of Infectious Diseases, Infection Control, and Employee Health, The University of Texas MD Anderson Cancer Center, Houston., Jiang Y; Department of Infectious Diseases, Infection Control, and Employee Health, The University of Texas MD Anderson Cancer Center, Houston., Blanchard T; Oxford Immunotec Incorporation, Marlborough, Massachusetts., Ghantoji SS; Department of Infectious Diseases, Infection Control, and Employee Health, The University of Texas MD Anderson Cancer Center, Houston., El Chaer F; Department of Infectious Diseases, Infection Control, and Employee Health, The University of Texas MD Anderson Cancer Center, Houston., El-Haddad D; Department of Infectious Diseases, Infection Control, and Employee Health, The University of Texas MD Anderson Cancer Center, Houston., Prayag A; Department of Infectious Diseases, Infection Control, and Employee Health, The University of Texas MD Anderson Cancer Center, Houston., Nesher L; Department of Infectious Diseases, Infection Control, and Employee Health, The University of Texas MD Anderson Cancer Center, Houston., Rezvani K; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston., Shpall E; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston., Chemaly RF; Department of Infectious Diseases, Infection Control, and Employee Health, The University of Texas MD Anderson Cancer Center, Houston.
Publikováno v:
The Journal of infectious diseases [J Infect Dis] 2019 Feb 23; Vol. 219 (6), pp. 898-907.
Autor:
Marty FM; Dana-Farber Cancer Institute, Boston, Massachusetts; Division of Infectious Diseases, Brigham and Women's Hospital, Boston, Massachusetts. Electronic address: fmarty@bwh.harvard.edu., Winston DJ; Department of Medicine, Ronald Reagan UCLA Medical Center, Los Angeles, California., Chemaly RF; Department of Infectious Diseases, Infection Control, and Employee Health, University of Texas M.D. Anderson Cancer Center, Houston, Texas., Mullane KM; Department of Medicine, University of Chicago, Chicago, Illinois., Shore TB; Department of Medicine, Weill Cornell Medical College/New York Presbyterian Hospital, New York, New York., Papanicolaou GA; Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York., Chittick G; Chimerix, Inc, Durham, North Carolina., Brundage TM; Chimerix, Inc, Durham, North Carolina., Wilson C; Chimerix, Inc, Durham, North Carolina., Morrison ME; Chimerix, Inc, Durham, North Carolina., Foster SA; Chimerix, Inc, Durham, North Carolina., Nichols WG; Chimerix, Inc, Durham, North Carolina., Boeckh MJ; Department of Medicine, University of Washington, Seattle, Washington; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington.
Publikováno v:
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation [Biol Blood Marrow Transplant] 2019 Feb; Vol. 25 (2), pp. 369-381. Date of Electronic Publication: 2018 Oct 04.
Autor:
El Chaer F; Department of Infectious Diseases, Infection Control, and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, TX; and.; Section of Infectious Diseases, Department of Medicine, Baylor College of Medicine, Houston, TX., Shah DP; Department of Infectious Diseases, Infection Control, and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, TX; and., Chemaly RF; Department of Infectious Diseases, Infection Control, and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, TX; and.
Publikováno v:
Blood [Blood] 2016 Dec 08; Vol. 128 (23), pp. 2624-2636. Date of Electronic Publication: 2016 Oct 19.
Autor:
Ariza-Heredia EJ; Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Nesher L, Chemaly RF
Publikováno v:
Cancer letters [Cancer Lett] 2014 Jan 01; Vol. 342 (1), pp. 1-8. Date of Electronic Publication: 2013 Sep 13.